MDxHealth SA Cash & Equivalents Growth & History (MDXH)

MDxHealth SA's cash and equivalents was $29.0M for fiscal 2025.

View full MDxHealth SA company overview

MDxHealth SA annual cash and equivalents history

MDxHealth SA annual cash and equivalents

Fiscal yearPeriod endedCash and equivalentsChangeGrowth
20252025-12-31$29.0M−$17.8M−37.96%
20242024-12-31$46.8M$24.4M+109.11%
20232023-12-31$22.4M$6.9M+44.36%
20222022-12-31$15.5M−$43.0M−73.50%
20212021-12-31$58.5M$42.5M+266.69%
20202020-12-31$16.0M

MDxHealth SA cash and equivalents trends

Over the last five fiscal years, MDxHealth SA's cash and equivalents increased from $16.0M to $29.0M, a change of $13.1M. The latest reported quarter, Q2 2026, shows $19.2M.

About the metric

What cash and equivalents mean

Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.

Calculation and source

Reported cash and equivalents

TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review MDxHealth SA source filings ↗

Community posts

It’s quiet here.

No posts about MDXH yet. Start the conversation.

Write the first post